Andrade Robert sold FENC
August 27, 2026 · Form 4 insider transaction
Andrade Robert sold 75,000 shares of Fennec Pharmaceuticals Inc. at $11.78 per share, a transaction worth $883.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
75,000
Price
$11.78
Total value
$883.5K
InsiderAndrade Robert
RoleOfficer
SecurityCommon shares
Transaction codeS: Open-market sale
Transaction dateAugust 27, 2026
Filing dateAugust 28, 2026
Shares owned after217,675
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). A portion of the sales proceeds from this transaction will be used by the reporting person to pay tax obligations of the reporting person.